Patent application number | Description | Published |
20090305894 | use of sulfonanilides as herbicide - Herbicidal compositions comprising containing sulfonanilides of the formula (I), wherein R | 12-10-2009 |
20100216792 | Pesticidal arylpyrrolidines - The invention is directed to arylpyrrolidines compounds which exhibit excellent insecticidal efficacy and which may be used as in the agrochemical field or in the field of veterinary medicine. The compounds are represented by formula (I): | 08-26-2010 |
20100305124 | Acylated Aminopyridine and Aminopyridazine Insecticides - The present invention relates to aminopyridine and aminopyridazine derivatives of the general formula (I) | 12-02-2010 |
20100323896 | USE OF SULFONANILIDES AS HERBICIDE - Herbicidal compositions comprising containing sulfonanilides of the formula (I) | 12-23-2010 |
20110071141 | Pesticidial Condensed-Ring Aryl Compounds - Condensed-ring aryl compounds of formula (I) and use of the same as a agrochemical for controlling noxious organisms wherein (X) | 03-24-2011 |
20110237800 | HERBICIDE TRIAZOLYLPYRIDINE KETONES - Triazolylpyridine ketones expressed by the following formula (I) and use thereof as herbicides. | 09-29-2011 |
20120029202 | Process for the Preparation of 5-Substituted 3-Aryl-3-(trifluoromethyl)-3,4-dihydro-2H-pyrroles - The present invention relates to a process for the manufacturing of 5-substituted 3-aryl-3-(trifluoromethyl)-3,4-dihydro-2H-pyrroles of formula (I) | 02-02-2012 |
20120129854 | Pesticidal Arylpyrrolidines - The invention is directed to arylpyrrolidines compounds which exhibit excellent insecticidal efficacy and which may be used as in the agrochemical field or in the yield of veterinary medicine. The compounds are represented by formula (I): wherein the respective substituents are defined in the specification. | 05-24-2012 |
20120149910 | Pesticidal Carboxamides - The object of the present invention is to provide novel carboxamides which exhibit an excellent pesticidal activity as pesticides. Disclosed are the carboxamides represented by the following Formula (I): | 06-14-2012 |
20130310408 | Pesticidal Arylpyrrolidines - The invention is directed to arylpyrrolidines compounds which exhibit excellent insecticidal efficacy and which may be used as in the agrochemical field or in the vield of veterinary medicine. The compounds are represented by formula (I): | 11-21-2013 |
20140046069 | PESTICIDAL ARYLPYRROLIDINES - Arylpyrrolidines of Formula (I): wherein each substituent is as defined in the specification, and use thereof as pesticides and animal paracite-controlling agents. | 02-13-2014 |
20150073139 | Pesticidal Arylpyrrolidines - The invention is directed to arylpyrrolidines compounds which exhibit excellent insecticidal efficacy and which may be used as in the agrochemical field or in the vield of veterinary medicine. The compounds are represented by formula (I): | 03-12-2015 |
Patent application number | Description | Published |
20080312084 | DIFLUOROMETHANESFONYL ANILIDE DERIVATIVES USEFUL AS HERBICIDES - Novel difluoromethanesulfonamide derivatives of the formula (I) Difluoromethanesulfonamide derivatives represented by the formula | 12-18-2008 |
20090062536 | USE OF SULFONANILIDE COMPOUNDS AS HERBICIDE - A herbicide comprising as an active ingredient a sulfonanilide compound represented by the formula: | 03-05-2009 |
20110009457 | Aminobenzamide Derivatives as Useful Agents for Controlling Animal Parasistes - The invention relates to a composition comprising at least one aminobenzamide compound or a salt thereof for controlling animal parasites, veterinary pharmaceutical compositions comprising at least one aminobenzamide of formula (I) for preventing infection with diseases transmitted through parasites, its use for the preparation of a veterinary pharmaceutical for controlling animal parasites, and a method for preventing infection with diseases transmitted through parasites. | 01-13-2011 |
20120214851 | Aminobenzamide Derivatives as Useful Agents for Controlling Animal Parasites - The invention relates to a composition comprising at least one aminobenzamide compound or a salt thereof for controlling animal parasites, veterinary pharmaceutical compositions comprising at least one aminobenzamide of formula (I) for preventing infection with diseases transmitted through parasites, its use for the preparation of a veterinary pharmaceutical for controlling animal parasites, and a method for preventing infection with diseases transmitted through parasites. | 08-23-2012 |
20120277185 | Pesticidal Carboxamides - To provide novel carboxamides which exhibit an excellent pesticidal activity as pesticides. Carboxamides represented by the following Formula (I) and use thereof as pesticides and an animal parasite control agent: | 11-01-2012 |
20130296168 | HERBICIDE TRIAZOLYLPYRIDINE KETONES - Triazolylpyridine ketones expressed by the following formula (1) and use thereof as herbicides. | 11-07-2013 |
Patent application number | Description | Published |
20110129496 | Use of mTOR Inhibitors to Enhance T Cell Immune Responses - It is disclosed herein that treatment of a subject with an mTOR inhibitor enhances antigen-specific T cell immune responses. Thus, provided herein is a method of enhancing an antigen-specific T cell response in a subject by administering to the subject a therapeutically effective amount of an mTOR inhibitor. The antigen can be any antigen, such as an antigen from a pathogen or a vaccine, or a tumor antigen. In some embodiments, the method further comprises administering to the subject a vaccine, such as a virus vaccine or a cancer vaccine. The mTOR inhibitor can be administered either before or after vaccination to enhance the quantity and quality of the T cell immune response and immunological memory. In some examples, the mTOR inhibitor is rapamycin or a rapamycin analog. | 06-02-2011 |
20140370059 | USE OF mTOR INHIBITORS TO ENHANCE T CELL IMMUNE RESPONSES - It is disclosed herein that treatment of a subject with an mTOR inhibitor enhances antigen-specific T cell immune responses. Thus, provided herein is a method of enhancing an antigen-specific T cell response in a subject by administering to the subject a therapeutically effective amount of an mTOR inhibitor. The antigen can be any antigen, such as an antigen from a pathogen or a vaccine, or a tumor antigen. In some embodiments, the method further comprises administering to the subject a vaccine, such as a virus vaccine or a cancer vaccine. The mTOR inhibitor can be administered either before or after vaccination to enhance the quantity and quality of the T cell immune response and immunological memory. In some examples, the mTOR inhibitor is rapamycin or a rapamycin analog. | 12-18-2014 |